Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Courses Quicksearch

Search Now!

Courses

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Doug Helmersen

0 comments
Leave a Comment

Course ID: 2179

Course Author

Doug Helmersen, MD, FRCPC
Clinical Assistant Professor
Department of Medicine
University of Calgary
Calgary, Alberta, Canada

Course Reviewer

Robert P. Frantz, MD
Director, Mayo Pulmonary Hypertension Clinic
Director, Cardiovascular Studies Unit
Associate Professor of Medicine, Cardiovascular Diseases and Internal Medicine
Mayo Clinic
Rochester, Minn.

Murali Chakinala, MD
Associate Professor
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine
St. Louis, Missouri

W. Edwin Dodson, MD 
Associate Vice Chancellor and Associate Dean for Admissions and Continuing Medical Education
Professor of Pediatrics and Neurology
Washington University School of Medicine
St. Louis, Missouri 

Learning Objectives

Upon successful completion of this course, participants will be able to: 

  1. Define chronic thromboembolic pulmonary hypertension (CTEPH).
  2. Describe the pathophysiology of CTEPH.
  3. List the possible risk factors for CTEPH.
  4. Formulate an algorithm to diagnose CTEPH using the appropriate diagnostic tools.
  5. Identify treatment options including surgical and medical interventions.

Release Date

24 April 2013

Expiration Date

24 April 2015

Accreditation and Credit

Washington University in St Louis School of Medicine Logo

 This enduring activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Washington University School of Medicine, Continuing Medical Education and the Pulmonary Hypertension Association. 

Washington University is accredited by the ACCME to provide continuing medical education for physicians.

Washington University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  Washington University designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy 

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All faculty participating in this activity are expected to disclose to the audience any financial interest or other relationship he/she has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation.

All physicians' disclosures were reported and are indicated with their presentations. Any potential conflict was addressed and resolved.

Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are the views and experiences of the presenters.  The presenters' views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education is the sponsor for CME credits.

Instructions for Earning Credit

This activity is a self-study program. Upon entering the activity, participants should read the text, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be asked to complete a post-test and evaluation online. Participants must receive a test score of 100% in order to proceed to the course evaluation; the post-test can be repeated until all questions are answered correctly. All evaluation questions must be completed in order to receive a certificate of credit. If needed, participants may save their answers and complete the course at a later date. Saved courses can be found by using the "My Courses" link at the top of the page, and then click on "My Classes."

Faculty Disclosures

The Accreditation Council for Continuing Medical Education and the Association of American Colleges have standards and guidelines to ensure that individuals participating in CME activities are aware of relationships between authors and commercial companies that could potentially affect the information presented. To be disclosed to participants are all personal financial relationships with a commercial interest whose products are relevant to the content of this CME activity. It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in this activity are expected to disclose to the audience any financial interest or other potential conflict. Each author/planner was asked to complete a disclosure information form for this activity. Disclosures are reported below:

Doug Helmersen, MD, FRCPC, indicates that he has received research support/grants from Bayer, Novartis, Pfizer and Actelion.

Robert P. Frantz, MD, has worked as a consultant for Pfizer and has received grant/research support from United Therapeutics.

Murali Chakinala, MD, indicates that he receives research support or serves as a consultant to Actelion, Gilead, United Therapeutics, Lung LLC, Novartis, and Ikaria.

W. Edwin Dodson, MD, indicates that he has financial relationship to disclose.

Disclaimer

The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), Washington University in St. Louis, or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.

Estimated Time to Complete This Activity

1 hour

Privacy Policy

For information about the PHA's privacy policy, visit http://www.PHAssociation.org/PrivacyPolicy

This activity is made possible through educational grants from Actelion, Gilead, Pfizer and United Therapeutics.

©2012 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.

 

Technical Requirements

Web Browser:  For optimal viewing use Mozilla Firefox or Safari.